These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3004519)

  • 41. Inhibition of the thrombin-platelet reactions by DuP 714.
    Chiu AT; Mousa SA; Pease LJ; Roscoe WA; Bozarth JM; Reilly TM; Smith RD; Timmermans PB
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1500-8. PubMed ID: 1930190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stimulus-induced release of endogenous catecholamines from human washed platelets.
    Smith CC; Wilson AP; Prichard BN; Betteridge DJ
    Clin Sci (Lond); 1986 May; 70(5):495-500. PubMed ID: 3698518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma catecholamine modulation of alpha 2 adrenoreceptor agonist affinity and sensitivity in normotensive and hypertensive human platelets.
    Hollister AS; Onrot J; Lonce S; Nadeau JH; Robertson D
    J Clin Invest; 1986 May; 77(5):1416-21. PubMed ID: 3009543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet aggregation and release: effects of low concentrations of thrombin or collagen.
    Packham MA; Guccione MA; Chang PL; Mustard JF
    Am J Physiol; 1973 Jul; 225(1):38-47. PubMed ID: 4714409
    [No Abstract]   [Full Text] [Related]  

  • 48. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M
    Acta Pol Pharm; 2009; 66(3):235-42. PubMed ID: 19645323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of adrenaline on human blood platelets.
    Mills DC; Roberts GC
    J Physiol; 1967 Nov; 193(2):443-53. PubMed ID: 6065889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity.
    Westerbacka J; Yki-Järvinen H; Turpeinen A; Rissanen A; Vehkavaara S; Syrjälä M; Lassila R
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):167-72. PubMed ID: 11788478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alpha-adrenoceptor-mediated actions of optical isomers and desoxy analogs of catecholimidazoline and norepinephrine in human platelets: in vitro.
    Ahn CH; Hamada A; Miller DD; Feller DR
    Biochem Pharmacol; 1986 Nov; 35(22):4095-102. PubMed ID: 3022751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and alpha 2-adrenoceptor effects of substituted catecholimidazoline and catecholimidazole analogues in human platelets.
    Miller DD; Hamada A; Clark MT; Adejare A; Patil PN; Shams G; Romstedt KJ; Kim SU; Intrasuksri U; McKenzie JL
    J Med Chem; 1990 Apr; 33(4):1138-44. PubMed ID: 2157007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
    J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute and chronic regulation of alpha 2-adrenoceptor number and function in man.
    Jones CR; Hamilton CA; Whyte KF; Elliott HL; Reid JL
    Clin Sci (Lond); 1985; 68 Suppl 10():129s-132s. PubMed ID: 2857608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Butyltin compounds in vitro inhibition of human platelet epinephrine-induced aggregation and blockade of epinephrine binding to platelets.
    Yanagisawa H; Wada O
    Ind Health; 1985; 23(4):255-68. PubMed ID: 3938784
    [No Abstract]   [Full Text] [Related]  

  • 60. The interaction of platelets and concanavalin A.
    Kaplan KL; Nachman RL
    Thromb Res; 1975 Dec; 7(6):847-59. PubMed ID: 1198553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.